Where appropriate, dihexa is provided only within a physician-supervised plan with proper evaluation, medical-grade sourcing, and monitoring by providers who specialize in peptides and have guided thousands of patients
A 2019 study published in Diabetes Care (Frias et al.) examined the combination of semaglutide with an SGLT2 inhibitor and found additive reductions in both HbA1c and body weight compared to either medication used alone, with no significant increase in adverse events beyond what was expected from each medication individually
doi: 10.1186/s13024-017-0218-4, 155 ZilkaO.ShahR.LiB.FriedmannA
Oxidative toxicity in diabetes and Alzheimers disease: mechanisms behind ROS/ RNS generation
References are included at the end of the article when scientific, medical, or health-related claims are discussed
Regular follow-ups with a healthcare provider will help track improvements in attention, behavior, and eating patterns